YouTube

Join us for a series of free, monthly audio discussions with glaucoma specialists and other eye care professionals. Learn tips for living with glaucoma, the latest treatments, and promising research on the horizon. Presented by National Glaucoma Research, a BrightFocus Foundation program, and the American Glaucoma Society. Wednesday, July 10, 2024 1:00 pm EST (please adjust for your time zone) Featuring: Natasha Nayak Kolomeyer, MD Glaucoma Specialist and Ophthalmologist, Wills Eye Hospital Missed an

Read the full article here

Source: www.brightfocus.org

Categories: Ophthalmology, General Medicine News

Tweets with this article

American Glaucoma Society

Mark your calendar for AGS/BrightFocus Foundation’s next Glaucoma Chat on July 10, for an update on glaucoma drops with expert guest Dr. Natasha Kolomeyer. Learn how they work, potential side effects, and tips for managing challenges. Register: https://t.co/NvgbDTPfcJ https://t.co/6O0vCfzPYJ

Related Articles

Women advised to take part in Dry January to reduce dry eye risk

A study conducted on over 77,000 individuals found that alcohol consumption increased the risk of dry eye in women.

Ophthalmology Times January 8, 2025

Brazilian study links conjunctival bacteria to higher fluoroquinolone resistance

Ophthalmology Times – ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

Ophthalmology Times January 8, 2025

– Evolve Medical Education

Continuing Education Made Easy. Keep yourself in good standing with health care regulatory agencies and easily maintain your license

Retina Today January 7, 2025

Associations of Retinal Microvascular Density and Fractal Dimension with Glaucoma: A Prospective Study from UK Biobank

To explore the association between retinal microvascular parameters and glaucoma.

Ophthalmology January 7, 2025

Enfermedad ocular de Graves | National Eye Institute

Enfermedad ocular de Graves: ocurre cuando la hinchazón alrededor de los ojos los hace sobresalir. Producida por la enfermedad de Graves, autoinmunológica.

NEI January 7, 2025

Aviceda raises $207.5 million in Series C funding to advance geographic atrophy program

Aviceda Therapeutics secured $207.5 million in Series C financing to advance the AVD-104 program in geographic atrophy, according to a press release.

Ocular Surgery News January 7, 2025

Ocugen announces it will continue second phase of OCU410 ArMaDa clinical trial

ArMaDa clinical trial is set to assess the safety and efficacy of unilateral subretinal administration of OCU410 in subjects with GA

Ophthalmology Times January 7, 2025

Glaucoma Today

GT delivers important information on recent research, surgical techniques, clinical strategies, therapeutics, and technology.

Glaucoma Today January 7, 2025

Sozinibercept Shows Efficacy as DME Treatment

Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.

Retinal Physician January 7, 2025

Canyon Acquires iuvo

Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.

Glaucoma Physician January 7, 2025